Inventor · disambiguated record
Timothy Heffron
Also filed as: HEFFRON TIMOTHY
28 granted patents·7 pending applications·290 citations·filing 2009–2025
96Inventor score
Top patents by PatentIndex Score
35 records- 0198US8785626B2Benzoxazepin PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2013·Granted Jul 22, 2014·54 cites·4 claims
- 0297US8343955B2Benzoxazepin PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2012·Granted Jan 1, 2013·39 cites·31 claims
- 0396US8673952B2Benzoxepin PI3K inhibitor compounds and methods of useBLAQUIERE NICOLE·Filed 2012·Granted Mar 18, 2014·42 cites·22 claims
- 0496US8242104B2Benzoxazepin P13K inhibitor compounds and methods of useBLAQUIERE NICOLE·Filed 2010·Granted Aug 14, 2012·53 cites·33 claims
- 0595US11566003B2Isoquinolines as inhibitors of HPK1GENENTECH INC·Filed 2020·Granted Jan 31, 2023·4 cites·31 claims
- 0695US8586574B2Benzoxazepin PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2012·Granted Nov 19, 2013·19 cites·2 claims
- 0795US8263633B2Benzoxepin PI3K inhibitor compounds and methods of useBLAQUIERE NICOLE·Filed 2010·Granted Sep 11, 2012·29 cites·4 claims
- 0892US9212186B2Bicyclic pyrazole LRRK2 small molecule inhibitorsGENENTECH INC·Filed 2014·Granted Dec 15, 2015·11 cites·18 claims
- 0990US10407424B2Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2018·Granted Sep 10, 2019·5 cites·72 claims
- 1090US2025388599A1Tricyclic pi3k inhibitor compounds and methods of useGENENTECH INC·Filed 2025·Application pending·0 cites
- 1186US9890152B2Aminopyrimidine compounds as inhibitors of T790M containing EGFR mutantsGENENTECH INC·Filed 2015·Granted Feb 13, 2018·7 cites·29 claims
- 1285US9546178B2Benzoxazepin PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2015·Granted Jan 17, 2017·3 cites·8 claims
- 1384US9951064B2Azaindazole compounds as inhibitors of T790M containing EGFR mutantsGENENTECH INC·Filed 2016·Granted Apr 24, 2018·5 cites·15 claims
- 1482US8883799B2Tricyclic PI3K inhibitor compounds and methods of useDOTSON JENNAFER·Filed 2011·Granted Nov 11, 2014·6 cites·25 claims
- 1581US11034692B1Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2019·Granted Jun 15, 2021·1 cites·20 claims
- 1680US11612606B28-aminoisoquinoline compounds and uses thereofGENENTECH INC·Filed 2019·Granted Mar 28, 2023·2 cites·29 claims
- 1780US8952043B2Benzoxepin PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2014·Granted Feb 10, 2015·3 cites·21 claims
- 1878US9670228B2Benzoxazepin PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2016·Granted Jun 6, 2017·1 cites·4 claims
- 1977US8653098B2Pyrazolopyridine PI3K inhibitor compounds and methods of useDOTSON JENNAFER·Filed 2009·Granted Feb 18, 2014·3 cites·23 claims
- 2076US2022348593A1Tricyclic pi3k inhibitor compounds and methods of useGENENTECH INC·Filed 2021·Application pending·0 cites
- 2175US9546182B2Tricyclic PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2014·Granted Jan 17, 2017·2 cites·8 claims
- 2275US2024368170A1Cinnoline compounds and uses thereofGENENTECH INC·Filed 2024·Application pending·0 cites
- 2367US10952995B2Azaindoles as inhibitors of HPK1GENENTECH INC·Filed 2019·Granted Mar 23, 2021·0 cites·32 claims
- 2466US9175009B2Benzoxepin PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2014·Granted Nov 3, 2015·0 cites·5 claims
- 2566US2019330235A1Tricyclic p13k inhibitor compounds and methods of useGENENTECH INC·Filed 2019·Application pending·0 cites
- 2665US9198918B2Benzoxazepin PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2014·Granted Dec 1, 2015·0 cites·12 claims
- 2764US11944606B2Azaindoles as inhibitors of HPK1GENENTECH INC·Filed 2021·Granted Apr 2, 2024·0 cites·20 claims
- 2862US2022073520A1Cinnoline compounds and uses thereofGENENTECH INC·Filed 2021·Application pending·0 cites
- 2960US9090628B2Benzoxazepin compounds selective for PI3K P110 delta and methods of useHEFFRON TIMOTHY·Filed 2012·Granted Jul 28, 2015·1 cites·6 claims
- 3059US2017233407A1Tricyclic p13k inhibitor compounds and methods of useGENENTECH INC·Filed 2016·Application pending·0 cites
- 3154US12208088B2Spirocyclic 2,3-dihydro-7-azaindole compounds and uses thereofGENENTECH INC·Filed 2021·Granted Jan 28, 2025·0 cites·29 claims
- 3254US2018282282A1Isoquinolines as inhibitors of hpk1GENENTECH INC·Filed 2018·Application pending·0 cites
- 3353US12473301B2Isoquinoline compounds for the treatment of cancerGENENTECH INC·Filed 2021·Granted Nov 18, 2025·0 cites·18 claims
- 3453US12378249B2Isoquinoline compounds and uses thereofGENENTECH INC·Filed 2021·Granted Aug 5, 2025·0 cites·25 claims
- 3553US12297210B2Naphthyridine compounds and uses thereofGENENTECH INC·Filed 2021·Granted May 13, 2025·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Timothy Heffron files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →